Briefly, in this part of the study, we found that there was a requirement for new methylated genes other than PAX5 and TMPRSS2 to measure the effects of methylation inhibitor in breast cancer tissue in in vitro models. This evidence concerns the gene TMPRSS2 and breast cancer.